Charlson comorbidity index: a critical review of clinimetric properties
ME Charlson, D Carrozzino, J Guidi… - Psychotherapy and …, 2022 - karger.com
The present critical review was conducted to evaluate the clinimetric properties of the
Charlson Comorbidity Index (CCI), an assessment tool designed specifically to predict long …
Charlson Comorbidity Index (CCI), an assessment tool designed specifically to predict long …
Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies
Background A systematic understanding of how multimorbidity has been constructed and
measured is unavailable. This review aimed to examine the definition and measurement of …
measured is unavailable. This review aimed to examine the definition and measurement of …
National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States
Background Treating patients with infections due to multidrug-resistant pathogens often
requires substantial healthcare resources. The purpose of this study was to report estimates …
requires substantial healthcare resources. The purpose of this study was to report estimates …
Dissecting racial bias in an algorithm used to manage the health of populations
Health systems rely on commercial prediction algorithms to identify and help patients with
complex health needs. We show that a widely used algorithm, typical of this industry-wide …
complex health needs. We show that a widely used algorithm, typical of this industry-wide …
Mortality, length of stay, and healthcare costs associated with multidrug-resistant bacterial infections among elderly hospitalized patients in the United States
RE Nelson, D Hyun, A Jezek… - Clinical Infectious …, 2022 - academic.oup.com
Background This study reports estimates of the healthcare costs, length of stay, and mortality
associated with infections due to multidrug-resistant bacteria among elderly individuals in …
associated with infections due to multidrug-resistant bacteria among elderly individuals in …
[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
Measuring frailty in Medicare data: development and validation of a claims-based frailty index
Background Frailty is a key determinant of health status and outcomes of health care
interventions in older adults that is not readily measured in Medicare data. This study aimed …
interventions in older adults that is not readily measured in Medicare data. This study aimed …
Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study
D Arterburn, R Wellman, A Emiliano… - Annals of internal …, 2018 - acpjournals.org
Background: There has been a dramatic shift in use of bariatric procedures, but little is
known about their long-term comparative effectiveness. Objective: To compare weight loss …
known about their long-term comparative effectiveness. Objective: To compare weight loss …
Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: a cohort study
MD George, JF Baker, K Winthrop, JY Hsu… - Annals of internal …, 2020 - acpjournals.org
Background: Low-dose glucocorticoids are frequently used for the management of
rheumatoid arthritis (RA) and other chronic conditions, but the safety of long-term use …
rheumatoid arthritis (RA) and other chronic conditions, but the safety of long-term use …
Comparative cardiovascular effectiveness and safety of SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors according to frailty in type 2 diabetes
A Kutz, DH Kim, DJ Wexler, J Liu… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE To evaluate the comparative cardiovascular effectiveness and safety of sodium–
glucose cotransporter 2 inhibitors (SGLT-2is), glucagon-like peptide 1 receptor agonists …
glucose cotransporter 2 inhibitors (SGLT-2is), glucagon-like peptide 1 receptor agonists …